Cargando…

Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2

For the past 2 years, the coronavirus responsible for the COVID-19 infection has become a world pandemic, ruining the lives and economies of several nations in the world. This has scaled up research on the virus and the resulting infection with the goal of developing new vaccines and therapies. Natu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebob, Oyere Tanyi, Babiaka, Smith B., Ntie-Kang, Fidele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435765/
https://www.ncbi.nlm.nih.gov/pubmed/34515981
http://dx.doi.org/10.1007/s13659-021-00317-w
_version_ 1783751866822164480
author Ebob, Oyere Tanyi
Babiaka, Smith B.
Ntie-Kang, Fidele
author_facet Ebob, Oyere Tanyi
Babiaka, Smith B.
Ntie-Kang, Fidele
author_sort Ebob, Oyere Tanyi
collection PubMed
description For the past 2 years, the coronavirus responsible for the COVID-19 infection has become a world pandemic, ruining the lives and economies of several nations in the world. This has scaled up research on the virus and the resulting infection with the goal of developing new vaccines and therapies. Natural products are known to be a rich source of lead compounds for drug discovery, including against infectious diseases caused by microbes (viruses, bacteria and fungi). In this review article, we conducted a literature survey aimed at identifying natural products with inhibitory concentrations against the coronaviruses or their target proteins, which lie below 10 µM. This led to the identification of 42 compounds belonging to the alkaloid, flavonoid, terpenoid, phenolic, xanthone and saponin classes. The cut off concentration of 10 µM was to limit the study to the most potent chemical entities, which could be developed into therapies against the viral infection to make a contribution towards limiting the spread of the disease.
format Online
Article
Text
id pubmed-8435765
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-84357652021-09-13 Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2 Ebob, Oyere Tanyi Babiaka, Smith B. Ntie-Kang, Fidele Nat Prod Bioprospect Review For the past 2 years, the coronavirus responsible for the COVID-19 infection has become a world pandemic, ruining the lives and economies of several nations in the world. This has scaled up research on the virus and the resulting infection with the goal of developing new vaccines and therapies. Natural products are known to be a rich source of lead compounds for drug discovery, including against infectious diseases caused by microbes (viruses, bacteria and fungi). In this review article, we conducted a literature survey aimed at identifying natural products with inhibitory concentrations against the coronaviruses or their target proteins, which lie below 10 µM. This led to the identification of 42 compounds belonging to the alkaloid, flavonoid, terpenoid, phenolic, xanthone and saponin classes. The cut off concentration of 10 µM was to limit the study to the most potent chemical entities, which could be developed into therapies against the viral infection to make a contribution towards limiting the spread of the disease. Springer Singapore 2021-09-13 /pmc/articles/PMC8435765/ /pubmed/34515981 http://dx.doi.org/10.1007/s13659-021-00317-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Ebob, Oyere Tanyi
Babiaka, Smith B.
Ntie-Kang, Fidele
Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2
title Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2
title_full Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2
title_fullStr Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2
title_full_unstemmed Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2
title_short Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2
title_sort natural products as potential lead compounds for drug discovery against sars-cov-2
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435765/
https://www.ncbi.nlm.nih.gov/pubmed/34515981
http://dx.doi.org/10.1007/s13659-021-00317-w
work_keys_str_mv AT eboboyeretanyi naturalproductsaspotentialleadcompoundsfordrugdiscoveryagainstsarscov2
AT babiakasmithb naturalproductsaspotentialleadcompoundsfordrugdiscoveryagainstsarscov2
AT ntiekangfidele naturalproductsaspotentialleadcompoundsfordrugdiscoveryagainstsarscov2